Literature DB >> 30452329

Primary Sjögren's syndrome.

S J Bowman1.   

Abstract

Primary Sjögren's syndrome (pSS) is a systemic autoimmune disorder characterized by focal lymphocytic infiltration of the exocrine glands causing dry eyes and dry mouth. Similar glandular features can also occur as a late complication in patients with other rheumatic disorders, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and scleroderma ('secondary' Sjögren's syndrome).1 Anti-Ro and/or anti-La (ENA) antibodies are found in approximately 70% of pSS patients, generally with ANA positivity. Hypergammaglobulinaemia is also common. Systemic features also occur in some patients with pSS. A positive rheumatoid factor (RF) is often seen and so if patients present with arthritis, dryness and a positive RF a diagnosis of pSS should be considered as a possible alternative to RA. Anti-CCP antibodies are more specific for RA.

Entities:  

Keywords:  Dryness; Musculoskeletal; Sjögren’s syndrome; lymphoma

Mesh:

Substances:

Year:  2018        PMID: 30452329     DOI: 10.1177/0961203318801673

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  16 in total

Review 1.  Bilateral facial paralysis as a rare neurological manifestation of primary Sjögren's syndrome: case-based review.

Authors:  Zhang Wei; Shi Jiaying; Guo Junhong
Journal:  Rheumatol Int       Date:  2019-06-07       Impact factor: 2.631

2.  Autoimmune markers in screening for orbital inflammatory disease.

Authors:  Terence Ang; Valerie Juniat; Dinesh Selva
Journal:  Eye (Lond)       Date:  2022-04-19       Impact factor: 3.775

Review 3.  MAIT cells and their implication in human oral diseases.

Authors:  Qin Jiang; Fang Wang; Jing-Ya Yang; Gang Zhou
Journal:  Inflamm Res       Date:  2022-07-04       Impact factor: 6.986

Review 4.  Biology of interleukin-37 and its role in autoimmune diseases (Review).

Authors:  Huiqiong Zeng; Kaixia Zhou; Zhizhong Ye
Journal:  Exp Ther Med       Date:  2022-06-07       Impact factor: 2.751

5.  Increased risks of psychiatric disorders in patients with primary Sjögren's syndrome-a secondary cohort analysis of nationwide, population-based health claim data.

Authors:  Min-Chih Hsieh; Chia-Wen Hsu; Ming-Chi Lu; Malcolm Koo
Journal:  Clin Rheumatol       Date:  2019-08-01       Impact factor: 2.980

6.  Concomitant Sjögren's Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis.

Authors:  Ping Ni; Ruoting Men; Mengyi Shen; Tingting Wang; Chen Huang; Xiaoli Fan; Li Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2019-06-02

7.  LncRNA and mRNA expression profile of peripheral blood mononuclear cells in primary Sjögren's syndrome patients.

Authors:  Yu Peng; Xuan Luo; Yingying Chen; Linyi Peng; Chuiwen Deng; Yunyun Fei; Wen Zhang; Yan Zhao
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

Review 8.  Epstein-Barr Virus and Systemic Autoimmune Diseases.

Authors:  Gunnar Houen; Nicole Hartwig Trier
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

Review 9.  Effectiveness and Safety of Iguratimod in Treating Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Jincheng Pu; Xuan Wang; Farooq Riaz; Tongyangzi Zhang; Ronglin Gao; Shengnan Pan; Zhenzhen Wu; Yuanyuan Liang; Shuqi Zhuang; Jianping Tang
Journal:  Front Pharmacol       Date:  2021-03-19       Impact factor: 5.810

Review 10.  Emerging functions and clinical applications of exosomes in human oral diseases.

Authors:  Qiao Peng; Jing-Ya Yang; Gang Zhou
Journal:  Cell Biosci       Date:  2020-05-24       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.